Oleic Acid

Oleic Acid

SCHEMBL6002519

CCCCCCCC/C=C\CCCCCCCC(=O)O.OCC(O)CO.OCC(O)CO

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.77
▸ PPARD Q03181 5/20 0.77
▸ PPARA Q07869 5/20 0.77
▸ F7 P08709 5/20 0.77
▸ F3 P13726 5/20 0.77
▸ TERT O14746 3/20 0.77
▸ PTPN1 P18031 3/20 0.77
▸ HSD17B10 Q99714 3/20 0.77
▸ FABP4 P15090 3/20 0.77
▸ TOP1 P11387 3/20 0.77
▸ MAPT P10636 2/20 0.77
▸ BLM P54132 2/20 0.77
▸ LMNA P02545 2/20 0.77
▸ ALOX15 P16050 2/20 0.77
▸ DUSP3 P51452 2/20 0.77
▸ CYP19A1 P11511 2/20 0.77
▸ PTGS1 P23219 2/20 0.77
▸ NR4A2 P43354 2/20 0.77
▸ SIRT6 Q8N6T7 2/20 0.77
▸ PTPN7 P35236 2/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL10798920 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL5176449 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Glycerin SCHEMBL10796527 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL6574521 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL8848511 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Erucic Acid SCHEMBL25405469 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Erucic Acid SCHEMBL2457378 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL15049128 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL7931966 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL11276244 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3342821-B1 RESIN COMPOSITION AND RESIN MOLDED BODY ZEON CORP (JP) 2025-04-23 — — EP claimed
US-20240215588-A1 SPIDER MITE REPELLENT RIKEN (JP) 2024-07-04 — — US claimed
US-20240182773-A1 POROUS POLYURETHANE FOR CONSOLIDATION OF MATERIAL IN SUBTERRANEAN FORMATIONS SAUDI ARABIAN OIL COMPANY (SA) 2024-06-06 — — US claimed
EP-3032950-B1 SPRAY DRIFT REDUCTION CRODA INC (US) 2023-05-31 — — EP claimed
WO-2023032801-A1 METHOD FOR PRODUCING CELLULOSE BEADS 三井化学東セロ株式会社 2023-03-09 — — WO claimed
US-20220348814-A1 POROUS POLYURETHANE FOR CONSOLIDATION OF MATERIAL IN SUBTERRANEAN FORMATIONS SAUDI ARABIAN OIL COMPANY (SA) 2022-11-03 — — US claimed
WO-2022210840-A1 ORAL POUCH PRODUCT AND ORAL POUCH PRODUCT MANUFACTURING METHOD 日本たばこ産業株式会社 2022-10-06 — — WO claimed
CN-115135307-A Carrier for cell delivery 株式会社ITO 2022-09-30 — — CN claimed
WO-2026106828-A1 PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS THE PROCTER & GAMBLE COMPANY (US) 2026-05-21 — — WO disclosed
WO-2026107411-A1 PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS THE PROCTER & GAMBLE COMPANY (US) 2026-05-21 — — WO disclosed
US-20260138767-A1 PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS THE PROCTER & GAMBLE CO (US) 2026-05-21 — — US disclosed
US-20260137565-A1 PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS THE PROCTER & GAMBLE CO (US) 2026-05-21 — — US disclosed
EP-4731168-A1 OIL-IN-WATER EMULSION HAVING IMPROVED TEMPERATURE STABILITY, FOR OXIDATIVELY CHANGING THE COLOR OF KERATIN FIBERS Henkel AG & Co. KGaA (DE) 2026-04-29 — — EP disclosed
EP-4720139-A1 PROCESS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2026-04-08 — — EP disclosed
EP-3370664-B1 ABSORBENT ARTICLE COMPRISING AN ABSORBENT STRUCTURE PROCTER & GAMBLE (US) 2022-01-26 — — EP disclosed
CN-105169397-B A kind of method that hexagonal liquid crystal is prepared using amphipathic molecule 安徽中医药大学 2017-11-14 — — CN disclosed
US-20060188554-A1 Transdermal absorption preparation KYORIN PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 — — US disclosed
EP-1652523-A1 TRANSDERMAL ABSORPTION PREPARATION Kyorin Pharmaceutical Co., Ltd. (JP) 2006-05-03 — — EP disclosed
CN-1300225-A Absorbent member containing high surface area material for absorbing body fluids PROCTER & GAMBLE (US) 2001-06-20 — — CN disclosed
CN-1298289-A Absorbent members for absorbing body liquids PROCTER & GAMBLE (US) 2001-06-06 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137565-A1 PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS SHBG, SMCHD1, CUTA PPARG 3350/4885PPARD 2720/4885PPARA 3650/4885
US-20260138767-A1 PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS CUTA, SMCHD1, RFT1 PPARG 2894/4885PPARD 2325/4885PPARA 2782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback